A Patent With Potential to Disrupt the Global Tobacco Industry

Vireo Health: A 10 State Cannabis Operator

CEO of Vireo Health, Kyle Kingsley M.D, speaks about the cannabis company’s patent that covers the protective effects of cannabinoids when mixed with tobacco.

“Vireo Health is a 10 state cannabis operator in the United States focused on vertically integrated opportunities and the highest yield states such as New York, Pennsylvania, Minnesota, Maryland and Arizona.

Vireo Health has a position in scientific leadership which leads to disproportionate intellectual property opportunities like the recent patent that we were granted in the United States. The patent covers the protective effects of cannabinoids when mixed with tobacco. This has the potential not just to save lives but also to disrupt the nearly trillion dollar global tobacco industry.

We’re really in states that are early in the process, just getting started with the consumers. We actually have five full time positions on our team. Vireo is also stacked with appropriate legal teams and scientists and this drives a lot of opportunities in the MSO space. There’s also a great engineering team and partnerships on tap. They’re going to drive the next generation of processing equipment.

We are also excited about the next generation of packaging and the next generation of consumer products in the cannabis space.

Vireo is pretty uniquely differentiated as a multi-state operator because of our scientific and medical focus. I think that’s going to lead to advantages for us over the other multi-state operators. I’m not aware of any other companies that are so focused on replacing this terrible triad. We want to replace opioids, tobacco and alcohol. Building real replacements for that excites me as a physician and as a business person obviously if you can do those three things you’re looking at a pretty remarkable business.”

Multi-State Operator With a Scientific and Medical Focus

Vireo Health International, Inc.’s mission is to build the cannabis company of the future by bringing the best of medicine, engineering and science to the cannabis industry. Vireo’s physician-led team of more than 300 employees provides best-in-class cannabis products and customer experience. The company cultivates cannabis in environmentally-friendly greenhouses, manufactures pharmaceutical-grade cannabis. It also extracts, and sells its products at both company-owned and third-party dispensaries. Vireo is currently licensed in ten states including Arizona, Maryland, Massachusetts, Minnesota, Nevada, New Mexico, New York, Ohio, Pennsylvania, and Rhode Island.

They cultivate cannabis in their environmentally friendly greenhouses and manufactures pharmaceutical-grade cannabis extracts in their state-of-the-art labs. These products are then sold through Vireo-owned dispensaries to qualifying patients in Minnesota and New York. Vireo’s locations feature teams of patient care experts and licensed pharmacists who consult with patients to make sure they get right. Currently, Vireo distributes their products through third-party dispensaries in Pennsylvania, Maryland and Ohio.

The company’s team is comprised of physicians, scientists, and horticulturists that have been successful in a variety of settings and bring a broad spectrum of experience in best practices and evidence-based medicine.

For more information on Vireo Health International Inc. (VREO:CSE) please fill out the form below.

Request Investor Info